Suven Life Sciences registers rise of 16% in Q3

01 Feb 2012 Evaluate

Suven Life Sciences has registered a rise of 16.21% in net profit to Rs 1.29 crore for the third quarter ended December 31, 2011. The company had posted a net profit of Rs 1.11 crore in the corresponding period of previous fiscal.

The company’s net income from sales and services rose to Rs 48.72 crore for the third quarter, compared to Rs 32.06 crore in the same period previous fiscal, up by 51.97%.

In addition, the company said that with effect from December 31, 2011, Suven Nishtaa Pharma has become a wholly-owned subsidiary of the company. Further, the company said its board at its meeting held on January 31, 2012 has given its consent for amalgamation of Suven Nishtaa Pharma with Suven Life Sciences subject to the approval of the scheme by the High Court of Andhra Pradesh.

Suven Life Sciences Share Price

166.05 -1.75 (-1.04%)
26-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1719.20
Dr. Reddys Lab 1269.05
Cipla 1505.05
Zydus Lifesciences 911.50
Lupin 2112.95
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×